PRINT THIS PAGE One Equity acquires Oncology Therapeutics Network from Bristol-Myers Squibb15/12/2004. Source: AltAssets. 
 US One Equity Partners will acquire Oncology Therapeutics Network from pharmaceutical and health care company Bristol-Myers Squibb. The transaction is expected to be completed during the first quarter of 2005, pending regulatory approvals.
OTN is a distributor of pharmaceuticals to office-based oncologists. For the year ended December 31, 2003, OTN generated revenues of $2.2bn.
Bristol-Myers, the global pharmaceutical business, has undertaken a string of divestitures to allow it to focus more sharply on its strategic priorities.
OEP manages $3.5bn of investments and commitments for JPMorgan Chase.
Copyright © 2004 AltAssets
|
